Polypharmacy in the Elderly: A Marker of Increased Risk of Mortality in a Population-Based Prospective Study (NEDICES)

Gerontology

Volumn 61, Issue 4, 2015, Pages 301-309

  Gómez, Candelas ^a   Vega Quiroga, Saturio ^b   Bermejo Pareja, Félix ^c,d,e   Medrano, María José ^f   Louis, Elan D ^g,h,i,j   Benito León, Julián ^c,d,e  

^a 'Eras Del Bosque' Health Center   (Spain)

^b Health Center of Arévalo   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^e CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

^g Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^h Department of Neurology ^*  (United States)

ⁱ Columbia University ^*  (United States)

^j NONE   (United States)

more..

Author keywords

Elderly people; Epidemiology; Mortality; Polypharmacy

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; COMORBIDITY; DEMENTIA; FEMALE; FOLLOW UP; HAZARD RATIO; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; POLYPHARMACY; POPULATION RESEARCH; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; AGE; CASE CONTROL STUDY; EPIDEMIOLOGY; RISK FACTOR; SOCIOECONOMICS; SPAIN; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CAUSE OF DEATH; COMORBIDITY; FEMALE; HUMANS; MALE; POLYPHARMACY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; SPAIN;

EID: 84937523493     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000365328     Document Type: Article

References (40)

1. Lutz W, Sanderson W, Scherbov S: The coming acceleration of global population ageing. Nature 2008; 451: 716-719.
2. Remington PL, Brownson RC, Wegner MV: American Public Health Association: Chronic Disease Epidemiology and Control, ed 3. Washington, American Public Health Association, 2010.
3. Guralnik JM, Kaplan GA: Predictors of healthy aging: Prospective evidence from the alameda county study. Am J Public Health 1989; 79: 703-708.
4. Farrell B, Shamji S, Monahan A, French Merkley V: Reducing polypharmacy in the elderly: cases to help you 'rock the boat'. Can Pharm J (Ott) 2013; 146: 243-244.
5. Carbonin P, Pahor M, Bernabei R, Sgadari A: Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc 1991; 39: 1093-1099.
6. Haider SI, Johnell K, Thorslund M, Fastbom J: Analysis of the association between polypharmacy and socioeconomic position among elderly aged > or = 77 years in Sweden. Clin Ther 2008; 30: 419-427.
7. Colloca G, Tosato M, Vetrano DL, Topinkova E, Fialova D, Gindin J, van der Roest HG, Landi F, Liperoti R, Bernabei R, Onder G: Inappropriate drugs in elderly patients with severe cognitive impairment: results from the SHELTER study. PLoS One 2012; 7:e46669.
8. Vetrano DL, Tosato M, Colloca G, Topinkova E, Fialova D, Gindin J, van der Roest HG, Landi F, Liperoti R, Bernabei R, Onder G: Polypharmacy in nursing home residents with severe cognitive impairment: results from the SHELTER study. Alzheimers Dement 2013; 9: 587-593.
9. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA: Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey. JAMA 2002; 287: 337-344.
10. Hovstadius B, Hovstadius K, Astrand B, Petersson G: Increasing polypharmacy-an individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol 2010; 10: 16.
11. Shah BM, Hajjar ER: Polypharmacy, adverse drug reactions, and geriatric syndromes. Clin Geriatr Med 2012; 28: 173-186.
12. Zed PJ, Abu-Laban RB, Balen RM, Loewen PS, Hohl CM, Brubacher JR, Wilbur K, Wiens MO, Samoy LJ, Lacaria K, Purssell RA: Incidence, severity and preventability of medication-related visits to the emergency department: A prospective study. CMAJ 2008; 178: 1563-1569.
13. Colley CA, Lucas LM: Polypharmacy: The cure becomes the disease. J Gen Intern Med 1993; 8: 278-283.
14. Payne RA, Avery AJ: Polypharmacy: one of the greatest prescribing challenges in general practice. Br J Gen Pract 2011; 61: 83-84.
15. Espino DV, Bazaldua OV, Palmer RF, Mouton CP, Parchman ML, Miles TP, Markides K: Suboptimal medication use and mortality in an older adult community-based cohort: results from the Hispanic EPESE Study. J Gerontol A Biol Sci Med Sci 2006; 61: 170-175.
16. Jyrkkä J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S: Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging 2009; 26: 1039-1048.
17. Pozzi C, Lapi F, Mazzaglia G, Inzitari M, Boncinelli M, Geppetti P, Mugelli A, Marchionni N, Di Bari M: Is suboptimal prescribing a risk factor for poor health outcomes in community-dwelling elders? The ICARe Dicomano study. Pharmacoepidemiol Drug Saf 2010; 19: 954-960.
18. Benito-León J, Bermejo-Pareja F, Morales JM, Vega S, Molina JA: Prevalence of essential tremor in three elderly populations of central Spain. Mov Disord 2003; 18: 389-394.
19. Benito-León J, Bermejo-Pareja F, Rodríguez J, Molina JA, Gabriel R, Morales JM; Neurological Disorders in Central Spain (NEDICES) Study Group: Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain. Mov Disord 2003; 18: 267-274.
20. Benito-León J, Bermejo-Pareja F, Morales-González JM, Porta-Etessam J, Trincado R, Vega S, Louis ED; Neurological Disorders in Central Spain (NEDICES) Study Group: Incidence of Parkinson disease and parkinsonism in three elderly populations of central Spain. Neurology 2004; 62: 734-741.
21. Morales JM, Bermejo FP, Benito-León J, Rivera-Navarro J, Trincado R, Gabriel SR, Vega S; NEDICES Study Group: Methods and demographic findings of the baseline survey of the NEDICES cohort: A door-to-door survey of neurological disorders in three communities from central Spain. Public Health 2004; 118: 426-433.
22. Benito-León J, Bermejo-Pareja F, Louis ED; Neurological Disorders in Central Spain (NEDICES) Study Group: Incidence of essential tremor in three elderly populations of central Spain. Neurology 2005; 64: 1721-1725.
23. Louis ED, Benito-León J, Bermejo-Pareja F; Neurological Disorders in Central Spain (NEDICES) Study Group: Self-reported depression and anti-depressant medication use in essential tremor: cross-sectional and prospective analyses in a population-based study. Eur J Neurol 2007; 14: 1138-1146.
24. Bermejo-Pareja F, Benito-León J, Vega S, Medrano MJ, Román GC; Neurological Disorders in Central Spain (NEDICES) Study Group: Incidence and subtypes of dementia in three elderly populations of central Spain. J Neurol Sci 2008; 264: 63-72.
25. Louis ED, Benito-León J, Bermejo-Pareja F; Neurological Disorders in Central Spain (NEDICES) Study Group: Philadelphia geriatric morale scale in essential tremor: A population-based study in three Spanish communities. Mov Disord 2008; 23: 1435-1440.
26. Díaz-Guzmán J, Bermejo-Pareja F, Benito-León J, Vega S, Gabriel R, Medrano MJ; Neurological Disorders in Central Spain (NEDICES) Study Group: Prevalence of stroke and transient ischemic attack in three elderly populations of central Spain. Neuroepidemiology 2008; 30: 247-253.
27. Bermejo-Pareja F, Benito-León J, Vega S, Olazarán J, de Toledo M, Díaz-Guzmán J, Sánchez-Sánchez F, Morales-González JM, Trincado R, Portera-Sanchez A, Roman GC: Consistency of clinical diagnosis of dementia in NEDICES: A population-based longitudinal study in Spain. J Geriatr Psychiatry Neurol 2009; 22: 246-255.
28. Benito-León J, Louis ED, Bermejo-Pareja F; Neurological Disorders in Central Spain (NEDICES) Study Group: Population-based case-control study of morale in Parkinson's disease. Eur J Neurol 2009; 16: 330-336.
29. Martínez-Salio A, Benito-León J, Díaz-Guzmán J, Bermejo-Pareja F: Cerebrovascular disease incidence in central Spain (NEDICES): A population-based prospective study. J Neurol Sci 2010; 298: 85-90.
30. Vega S, Benito-León J, Bermejo-Pareja F, Medrano MJ, Vega-Valderrama LM, Rodríguez C, Louis ED: Several factors influenced attrition in a population-based elderly cohort: neurological disorders in central Spain study. J Clin Epidemiol 2010; 63: 215-222.
31. Benito-León J, Louis ED, Rivera-Navarro J, Medrano MJ, Vega S, Bermejo-Pareja F: Low morale is associated with increased risk of mortality in the elderly: A population-based prospective study (NEDICES). Age Ageing 2010; 39: 366-373.
32. Diagnostic and Statistical Manual of Mental Disorders DSM-IV. Washington, American Psychiatric Association, 1994.
33. Bushardt RL, Massey EB, Simpson TW, Ariail JC, Simpson KN: Polypharmacy: misleading, but manageable. Clin Interv Aging 2008; 3: 383-389.
34. Carey IM, Shah SM, Harris T, DeWilde S, Cook DG: A new simple primary care morbidity score predicted mortality and better explains between practice variations than the Charlson index. J Clin Epidemiol 2013; 66: 436-444.
35. Zhan C, Sangl J, Bierman AS, Miller MR, Friedman B, Wickizer SW, Meyer GS: Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA 2001; 286: 2823-2829.
36. Abrams WB, Beers MH: Clinical pharmacology in an aging population. Clin Pharmacol Ther 1998; 63: 281-284.
37. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH: Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716-2724.
38. Monane M, Monane S, Semla T: Optimal medication use in elders. Key to successful aging. West J Med 1997; 167: 233-237.
39. Tanaka E: Clinically significant pharmacokinetic drug interactions between antiepileptic drugs. J Clin Pharm Ther 1999; 24: 87-92.
40. Lassen LC: Patient compliance in general practice. Scand J Prim Health Care 1989; 7: 179-180.